Abbreviations
- HIPEC:
-
Hyperthermic intraperitoneal chemotherapy
- CRS:
-
Cytoreductive surgery
- PCI:
-
Peritoneal cancer index
- CC:
-
Completeness of cytoreduction
- DPAM:
-
Disseminated peritoneal adenomucinosis
- PMP:
-
Pseudomyxoma peritonei
References
Smeenk RM, Bruin SC, van Velthuysen ML, Verwaal VJ. Pseudomyxoma peritonei. Curr Probl Surg. 2008;45(8):527–75. https://doi.org/10.1067/j.cpsurg.2008.04.003. Review
Goodman MD, McPartland S, Detelich D, Saif MW. Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy. J Gastrointest Oncol. 2016;7(1):45–57. https://doi.org/10.3978/j.issn.2078-6891.2015.111. Review
Lungoci C, Mironiuc AI, Muntean V, Oniu T, Leebmann H, Mayr M, et al. Multimodality treatment strategies have changed prognosis of peritoneal metastases. World J Gastrointest Oncol. 2016;8(1):67–82. https://doi.org/10.4251/wjgo.v8.i1.67.
Sugarbaker PH. The natural history, gross pathology, and histopathology of appendiceal epithelial neoplasms. Eur J Surg Oncol. 2006;32:644–7.
Elias D, Gilly F, Quenet F, Bereder JM, Sidéris L, Mansvelt B, et al. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol. 2010;36:456–62.
Bhatt A, Mehta S, Seshadri RA, Sethna K, Zaveri S, Rajan F, et al. The initial Indian experience with cytoreductive surgery and HIPEC in the treatment of peritoneal metastases. Indian J Surg Oncol. 2016;7(2):160–5. https://doi.org/10.1007/s13193-016-0500-x. Epub 2016 Feb 2
Padmanabhan N, Kumar BR, Pookunju AP, Srinivasan A, Mahajan V. Preliminary experience and morbidity analysis of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) from a tertiary cancer center in India. J Clin Diagn Res. 2015;9(6):XC09–13. https://doi.org/10.7860/JCDR/2015/14216.6075.
Dharmadhikari N, Shah R, Jagannath P. Initial experience with hyperthermic intra peritoneal chemotherapy and cytoreductive surgery. Indian J Cancer. 2014;51(2):189–92. https://doi.org/10.4103/0019-509X.138304.
Votanopoulos K, Ihemelandu C, Shen P, Stewart J, Russell G, Levine EA. A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C. J Surg Res. 2013;179(1):e133–9. https://doi.org/10.1016/j.jss.2012.01.015.
Lambert LA, Armstrong TS, Lee JJ, Liu S, Katz MH, Eng C, et al. Incidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin C. Ann Surg Oncol. 2009;16(8):2181–7. https://doi.org/10.1245/s10434-009-0523-4.
Hinkle NM, MacDonald J, Sharpe JP, Dickson P, Deneve J, Munene G. Cytoreduction with hyperthermic intraperitoneal chemotherapy: an appraisal of outcomes and cost at a newly established peritoneal malignancy program. Am J Surg. 2016;212:413–8. https://doi.org/10.1016/j.amjsurg.2016.01.022.
Squires MH III, Staley CA, Knechtle W, Winer JH, Russell MC, Perez S, et al. Association between hospital finances, payer mix, and complications after hyperthermic intraperitoneal chemotherapy: deficiencies in the current healthcare reimbursement system and future implications. Ann Surg Oncol. 2015;22(5):1739–45. https://doi.org/10.1245/s10434-014-4025-7.
Cravioto-Villanueva A, Cavazos M, Luna-Perez P, Martinez-Gomez H, Ramirez ML, Solorzano J, et al. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin. Surg Today. 2016;46(8):979–84. https://doi.org/10.1007/s00595-016-1335-3.
Ortega-Deballon P, Facy O, Magnin G, Piard F, Chauffert B, Rat P. Using a heating cable within the abdomen to make hyperthermic intraperitoneal chemotherapy easier: feasibility and safety study in a pig model. Eur J Surg Oncol. 2010;36(3):324–8.
Author information
Authors and Affiliations
Contributions
Rana AKS: idea, clinical contribution, editing
Agarwal N: idea, clinical contribution, writing of manuscript, and editing
Dutta S: writing of manuscript and editing
Dokania MK: writing of manuscript and editing
Goyal H: writing of manuscript and editing.
Corresponding author
Ethics declarations
Ethics Approval and Consent to Participate
Informed consent was taken from the patient; the study is case report which conforms to the standards of the institutional ethics committee.
Consent for Publication
Informed consent was taken from the patient.
Availability of Data and Material
Not applicable.
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Rana, A.K.S., Agarwal, N., Dutta, S. et al. A Modified Low-Cost Technique of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Two Patients: a Solution for Pseudomyxoma Peritonei in the Indian Scenario?. J Gastrointest Canc 50, 983–990 (2019). https://doi.org/10.1007/s12029-018-0161-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-018-0161-9